Neuralace

AXON THERAPY mPNS® FOR PATIENTS

A New Hope of Relief for Chronic Pain Sufferers

A New Hope of Relief for
Chronic Pain Sufferers

Chronic Pain Management Without Incisions, Implants or Ablations

Discover the first and only 100% painless and non-invasive mPNS treatment for chronic neuropathic pain.

EXPERIENCE THE BREAKTHROUGH OF AXON THERAPY mPNS

What If Chronic Pain Could Be Treated Without Painful Invasive Measures?

Axon Therapy mPNS is changing lives every day without needles, scalpels, implants, or ablations.
Non-invasive and painless spot treatment
0 %
Avg. pain reduction after complete treatment protocol 1
0 %
Avg. pain reduction after just one treatment 1
0 %
Avg. time per treatment in established protocol
0 min
High-frequency magnetic pulses delivered per treatment
0
1 For respondent patients only, VA Augusta Clinical Equipment Evaluation (CEC)
PATIENT BENEFITS

A Monumental
Breakthrough in Chronic
Pain Management

A Monumental Breakthrough in Chronic Pain Management

For patients suffering from chronic neuropathic pain such as post-traumatic surgical pain, post amputation pain, and phantom limb pain, Axon Therapy mPNS is a magnetic PNS treatment that uses simple, non-invasive magnetic pulses to deliver the benefits of neuromodulation.

An Incision-Free,
Surgery-Free, Pain-
Free Treatment

An Incision-Free,
Surgery-Free, Pain-
Free Treatment

Axon Therapy mPNS is a 100% non-invasive treatment that involves no incisions, no leads, and no surgical implants of any kind.

To treat the damaged nerve area, an Axon Therapy technician simply positions the device coil near or above the skin to administer painless magnetic pulses that recondition the central nervous system by eliminating noxious pain signals to the brain.

Short Treatments with
Long-term Results

Short Treatments with Long-term Results

A single treatment of Axon Therapy administers 400 painless magnetic pulses in roughly 13.5 minutes, and for respondent patients, the results are swift.

After only one treatment, respondent patients experience a 48% decrease in pain on average, and a 70% average decrease after three treatments.1 After a complete treatment cycle, ⅔ of respondent patients report an average of 87% reduction in pain. It’s that simple, that effective, and the results are long-lasting.2

Chronic Pain Relief
with No Risks or Side Effects

Chronic Pain Relief
with No Risks or Side
Effects

Historically, treating neuropathic pain has involved opioids, injections, or surgical interventions, but Axon Therapy mPNS offers a new and painless path.

Unlike opioids, Axon Therapy presents zero risk of addiction. Unlike PNS, there’s zero surgical or injection pain. And unlike many neuropathic pain therapies, Axon Therapy is shown to provide sustained pain reduction after just one treatment.

Doctor Reviews

SIMPLE TREATMENT PROTOCOL

The Axon Therapy mPNS Treatment Schedule

With a series of 13.5-minute painless outpatient treatments delivered across 90 days, the Axon Therapy mPNS treatment protocol couldn’t be simpler.

Month 1

Week 1: 3 Treatments
1 treatment per day for 3 consecutive days
Week 2-4: Weekly
1 treatment per week

Month 2

Month 2: Bi-Weekly
2 treatments every 2 weeks (bi-monthly)

Month 3

Month 3 +: Monthly
1 treatment per month

ABOUT US

With Every Magnetic Pulse, We’re Changing Lives.

With Every Magnetic Pulse, We’re Changing Lives.

Meet the team employing painless magnetic pulses to revolutionize chronic neuropathic pain management for patients and healthcare providers.
Find Out More About Axon Therapy mPNS

Keith Warner

Chief Executive Officer

Proactive and engaging leader with expertise in advanced strategy development and implementation driving outstanding corporate growth. Over 25 years of senior level business acumen gained through key executive positions with leading large cap to venture stage startups within the life sciences and medical technology sectors. Experience in organization-building geared to achieve near and long term milestones both in domestic and international settings. Ability to deliver significant transformation and growth in financial performance, product development, investor fundraising, capital restructuring, P&L management, and strategic planning.